Last reviewed · How we verify
Efficacy of Gelclair™ in Reducing the Pain of Oral Mucositis in Children and Young People With Cancer (SC 2005 07)
RATIONALE: Polyvinylpyrrolidone-sodium hyaluronate gel may lessen the pain of oral mucositis, or mouth sores, in patients undergoing treatment for cancer. PURPOSE: This clinical trial is studying how well polyvinylpyrrolidone-sodium hyaluronate gel works in reducing pain from oral mucositis in young patients with cancer.
Details
| Lead sponsor | Children's Cancer and Leukaemia Group |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 50 |
| Start date | 2005-07 |
Conditions
- Brain and Central Nervous System Tumors
- Chordoma
- Kidney Cancer
- Leukemia
- Lymphoma
- Mucositis
- Neuroblastoma
- Pain
- Sarcoma
- Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
- polyvinylpyrrolidone-sodium hyaluronate gel
Primary outcomes
- Timing and intensity of oral pain
- Duration of action of polyvinylpyrrolidone-sodium hyaluronate gel
- Acceptability, effectiveness, and adherence to regimens including polyvinylpyrrolidone-sodium hyaluronate gel
- Symptoms, other than pain, considered important to the pediatric population
Countries
Ireland, United Kingdom